Back
Coffee Holding 10K Form
Sell
17
JVA
Coffee Holding
Last Price:
1.41
Seasonality Move:
13.24%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-09-14 | 10Q | JVA/Coffee Holding Quarterly |
2023-06-15 | 10Q | JVA/Coffee Holding Quarterly |
2023-04-28 | 10Q | JVA/Coffee Holding Quarterly |
2023-03-17 | 10Q | JVA/Coffee Holding Quarterly |
2022-09-14 | 10Q | JVA/Coffee Holding Quarterly |
2022-06-14 | 10Q | JVA/Coffee Holding Quarterly |
Receive JVA News And Ratings
See the #1 stock for the next 7 days that we like better than JVA
JVA Financial Statistics
Sales & Book Value
Annual Sales: | $68.17M |
---|---|
Cash Flow: | $4.59M |
Price / Cash Flow: | 3.32 |
Annual Sales: | $4.26 |
Price / Book: | 0.33 |
Profitability
EPS (TTM): | 0.01000 |
---|---|
Net Income (TTM): | $47.6K |
Gross Margin: | $10.96M |
Return on Equity: | 0.2% |
Return on Assets: | 0.12% |
Coffee Holding Earnings Forecast
Key Coffee Holding Financial Ratios
- The Gross Profit Margin over the past 27 years for JVA is 16.08%.
- The Selling, General & Administrative Expenses for JVA have been equal to 18.03% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is -67.42% of Operating Income.
- The Net Earning history of JVA is -1.23% of Total Revenues.
- Per Share Earnings over the last 27 years have been positive in 13 years.
Coffee Holding Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Food Products |
Sector: | Consumer Staples |
Current Symbol: | JVA |
CUSIP: | 192176 |
Website: | coffeeholding.com |
Debt
Debt-to-Equity Ratio: | 0.19 |
---|---|
Current Ratio: | 2.76 |
Quick Ratio: | 1.13 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
JVA Technical Analysis vs Fundamental Analysis
Sell
17
Coffee Holding (JVA)
is a Sell
Is Coffee Holding a Buy or a Sell?
-
Coffee Holding stock is rated a Sell
The current Coffee Holding [JVA] share price is $1.42. The Score for JVA is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.